A Real-World Retrospective Analysis of the Management of Advanced Urothelial Carcinoma in Canada.

"Conflicts of Interest F.A.M.: No conflict of interest; C.L.P. No conflict of interest; B.J.E.: BMS honoraria, Janssen honoraria, Pfizer honoraria, EMD Serono honoraria and travel expenses, Seagen honoraria, and Gilead honoraria; M.P.: BMS honoraria, EMD Serono honoraria, Seattle Genetics honoraria, and Merck honoraria; R.M.: BMS honoraria, EMD Serono honoraria, Merck honoraria, and Pfizer honoraria; R.R.S. The following authors received honoraria for moderating the focus groups: B.J.E., M.P., R.M., and R.R.S. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results."

"This research was funded by EMD Serono Canada, a business of Merck KGaA, grant number 202308.4398.QC."